Results 231 to 240 of about 12,852,096 (349)

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

On the ultimate disintegration products of the radioactive elements [PDF]

, 1905
B. B. Boltwood
openalex   +1 more source

Borcherds products everywhere

, 2015
Gritsenko, V., Poor, C., Yuen, D.
core   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Notes on the chemistry of certain Australian plant products, Part I

, 1922
Henry George Smith
openalex   +2 more sources

The Nature and Rates of Excretion of Radioactive Breakdown Products of I131-Albumin in the Rabbit [PDF]

, 1959
Frank Zizza, Terence J. Campbell, E. B. Reeve   +2 more
openalex   +1 more source

Avon Pledges $750,000 for Alternatives to Animal Testing [PDF]

, 1981
Avon Products, Inc.
core   +1 more source

In re Amazon.com [PDF]

, 2021
Consumer Products Safety Commission
core   +1 more source

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma

Molecular Oncology, EarlyView.
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh, Amelia Martinez Villarreal, Philippe Lefrançois, Jennifer Gantchev, Sriraam Sivachandran, Samy Abou Setah, Ivan V. Litvinov   +6 more
wiley   +1 more source

The Ionization Constant, Solubility Product, and Solubility of Abietic and Dehydroabietic Acid. [PDF]

, 1958
Vera Nyrén, Ernst L. Back, Christian Pedersen, K. Hartiala, S. Veige, E. Diczfalusy   +5 more
openalex   +1 more source